PAR-18-433 - NIBIB Exploratory/Developmental Research Grant Program (R21) (Clinical Trial Optional) is used for the submission of applications to the following Notices of Special Interest (NOSIs)
On This Page: 1
Active NOSIs
Title | Notice Number | Organization | Release Date |
Expiration Date |
Activity Code(s) |
---|
Expired NOSIs
Title | Notice Number | Organization | Release Date |
Expiration Date |
Activity Code(s) |
---|---|---|---|---|---|
Notice of Special Interest (NOSI): Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19) | NOT-EB-20-007 | NIBIB | Apr 10, 2020 | Aug 29, 2020 | R01, R21, R03 |